Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified vs Traditional Bowel Prep in IBD
NCT05485103Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2022
- Primary completion
- Jul 2024
- Modality
- Polymer-based Nanoparticles, Implantable Devices, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of polyethylene glycol and glycerol in inflammatory bowel disease (IBD), sponsored by Peking Union Medical College Hospital. Primary endpoints: Quality of bowel preparation and Number of participants with increased disease activity at 7 days. Status: unknown.
02
Drugs
polyethylene glycolglycerol
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT05485103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05485103.